10-Q Filing

COMMUNITY HEALTH SYSTEMS INC CIK: 1108109 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001193125-16-670154`
Period End Date	20160630
Filing Date	20160803
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	cyh-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 132 Cash Flow Statement 91 Comprehensive Income 31

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful patient accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$3.73B	USD	Point-in-time
Allowance for doubtful patient accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.11B	USD	Point-in-time
Other current assets of hospitals held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$5.00M	USD	Point-in-time
Other current assets of hospitals held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$17.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$184.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$365.00M	USD	Point-in-time
Noncurrent assets of hospitals held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$41.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$509.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$461.00M	USD	Point-in-time
Noncurrent assets of hospitals held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$26.00M	USD	Point-in-time
Current liabilities of hospitals held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.00M	USD	Point-in-time
Patient accounts receivable, net of allowance for doubtful accounts of $3,732 and $4,110 at June 30, 2016 and December 31, 2015, respectively	`AccountsReceivableNetCurrent`	$3.61B	USD	Point-in-time
Current liabilities of hospitals held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$3.00M	USD	Point-in-time
Patient accounts receivable, net of allowance for doubtful accounts of $3,732 and $4,110 at June 30, 2016 and December 31, 2015, respectively	`AccountsReceivableNetCurrent`	$3.18B	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Supplies	`Supplies`	$527.00M	USD	Point-in-time
Supplies	`Supplies`	$580.00M	USD	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$27.00M	USD	Point-in-time
Prepaid income taxes	`PrepaidTaxes`	$33.00M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$197.00M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and taxes	`PrepaidExpensesAndTaxes`	$217.00M	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets (including assets of hospitals held for sale of $5 and $17 at June 30, 2016 and December 31, 2015, respectively)	`OtherAssetsCurrent`	$567.00M	USD	Point-in-time
Other current assets (including assets of hospitals held for sale of $5 and $17 at June 30, 2016 and December 31, 2015, respectively)	`OtherAssetsCurrent`	$425.00M	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.17B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.84B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	113.73M	shares	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$14.91B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	113.64M	shares	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentGross`	$13.36B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	112.76M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	113.64M	shares	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.79B	USD	Point-in-time
Less accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.41B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.11B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.96B	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	0.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	975,549.00	shares	Point-in-time
Goodwill	`Goodwill`	$8.96B	USD	Point-in-time
Goodwill	`Goodwill`	$6.93B	USD	Point-in-time
Other assets, net (including assets of hospitals held for sale of $26 and $41 at June 30, 2016 and December 31, 2015, respectively)	`OtherAssetsNoncurrent`	$2.35B	USD	Point-in-time
Other assets, net (including assets of hospitals held for sale of $26 and $41 at June 30, 2016 and December 31, 2015, respectively)	`OtherAssetsNoncurrent`	$1.71B	USD	Point-in-time
Total assets	`Assets`	$22.43B	USD	Point-in-time
Total assets	`Assets`	$26.59B	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$229.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$253.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.26B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$979.00M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$208.00M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$227.00M	USD	Point-in-time
Accrued liabilities (including liabilities of hospitals held for sale of $3 and $6 at June 30, 2016 and December 31, 2015, respectively)	`AccruedLiabilitiesCurrent`	$1.29B	USD	Point-in-time
Accrued liabilities (including liabilities of hospitals held for sale of $3 and $6 at June 30, 2016 and December 31, 2015, respectively)	`AccruedLiabilitiesCurrent`	$1.36B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.73B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.07B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$15.11B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$16.56B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$388.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$593.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.66B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.70B	USD	Point-in-time
Total liabilities	`Liabilities`	$19.88B	USD	Point-in-time
Total liabilities	`Liabilities`	$21.92B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$571.00M	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityFairValue`	$546.00M	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 113,643,956 shares issued and outstanding at June 30, 2016, and 113,732,933 shares issued and 112,757,384 shares outstanding at December 31, 2015	`CommonStockValue`	$1.00M	USD	Point-in-time
Common stock, $.01 par value per share, 300,000,000 shares authorized; 113,643,956 shares issued and outstanding at June 30, 2016, and 113,732,933 shares issued and 112,757,384 shares outstanding at December 31, 2015	`CommonStockValue`	$1.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.96B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.97B	USD	Point-in-time
Treasury stock, at cost, no shares at June 30, 2016 and 975,549 shares at December 31, 2015	`TreasuryStockValue`	$7.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-63.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-73.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-90.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-70.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-64.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-89.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$19.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.13B	USD	Point-in-time
Total Community Health Systems, Inc. stockholders' equity	`StockholdersEquity`	$4.02B	USD	Point-in-time
Total Community Health Systems, Inc. stockholders' equity	`StockholdersEquity`	$1.90B	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$107.00M	USD	Point-in-time
Noncontrolling interests in equity of consolidated subsidiaries	`MinorityInterest`	$86.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.11B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.00B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$22.43B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$26.59B	USD	Point-in-time

Income Statement 132 line items

Line Item	Tag	Value	Unit	Period
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$5.61B	USD	1 Quarter
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$11.04B	USD	2 Qtrs
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$11.26B	USD	2 Qtrs
Operating revenues (net of contractual allowances and discounts)	`HealthCareOrganizationRevenue`	$5.29B	USD	1 Quarter
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.47B	USD	2 Qtrs
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.46B	USD	2 Qtrs
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$732.00M	USD	1 Quarter
Provision for bad debts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$700.00M	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.59B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$9.79B	USD	2 Qtrs
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.88B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$9.59B	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$4.47B	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$4.47B	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$2.15B	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$2.22B	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$1.56B	USD	2 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$759.00M	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$1.51B	USD	2 Qtrs
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$750.00M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$2.23B	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$2.23B	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$1.12B	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$1.06B	USD	1 Quarter
Government settlement and related costs	`LossContingencyAccrualProvision`	$1.00M	USD	2 Qtrs
Government settlement and related costs	`LossContingencyAccrualProvision`	$1.00M	USD	2 Qtrs
Government settlement and related costs	`LossContingencyAccrualProvision`	$-6.00M	USD	1 Quarter
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$49.00M	USD	2 Qtrs
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$81.00M	USD	2 Qtrs
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$55.00M	USD	1 Quarter
Electronic health records incentive reimbursement	`ElectronicHealthRecordsIncentiveReimbursement`	$31.00M	USD	1 Quarter
Rent	`LeaseAndRentalExpense`	$229.00M	USD	2 Qtrs
Rent	`LeaseAndRentalExpense`	$231.00M	USD	2 Qtrs
Rent	`LeaseAndRentalExpense`	$112.00M	USD	1 Quarter
Rent	`LeaseAndRentalExpense`	$113.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$574.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$276.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$291.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$587.00M	USD	2 Qtrs
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$6.00M	USD	1 Quarter
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$1.66B	USD	2 Qtrs
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$6.00M	USD	2 Qtrs
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$1.64B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$10.67B	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$8.95B	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$4.44B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$5.96B	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-1.38B	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$840.00M	USD	2 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$441.00M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-1.08B	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-481.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-496.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-246.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-239.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.00M	USD	2 Qtrs
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-16.00M	USD	2 Qtrs
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-9.00M	USD	1 Quarter
Gain on sale of investments in unconsolidated affiliates	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$94.00M	USD	2 Qtrs
Gain on sale of investments in unconsolidated affiliates	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$94.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$34.00M	USD	2 Qtrs
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$21.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$14.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$39.00M	USD	2 Qtrs
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.48B	USD	2 Qtrs
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$382.00M	USD	2 Qtrs
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$214.00M	USD	1 Quarter
(Loss) income from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.54B	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-138.00M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$74.00M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$130.00M	USD	2 Qtrs
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-112.00M	USD	2 Qtrs
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-1.37B	USD	2 Qtrs
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-1.41B	USD	1 Quarter
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$252.00M	USD	2 Qtrs
(Loss) income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$140.00M	USD	1 Quarter
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-1.00M	USD	1 Quarter
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-6.00M	USD	1 Quarter
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-17.00M	USD	2 Qtrs
Loss from operations of entities sold or held for sale	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-2.00M	USD	2 Qtrs
Impairment of hospitals sold or held for sale	`DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax`	$1.00M	USD	2 Qtrs
Impairment of hospitals sold or held for sale	`DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax`	$2.00M	USD	2 Qtrs
Loss on sale, net	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-1.00M	USD	2 Qtrs
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-3.00M	USD	2 Qtrs
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-6.00M	USD	1 Quarter
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-20.00M	USD	2 Qtrs
Loss from discontinued operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$232.00M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-1.41B	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$134.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.37B	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$26.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$50.00M	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$23.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$43.00M	USD	2 Qtrs
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-1.42B	USD	2 Qtrs
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$-1.43B	USD	1 Quarter
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$111.00M	USD	1 Quarter
Net (loss) income attributable to Community Health Systems, Inc. stockholders	`NetIncomeLoss`	$189.00M	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.02	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-12.82	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.82	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicShare`	$-12.90	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.06	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.03	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.17	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	1 Quarter
Net (loss) income	`EarningsPerShareBasic`	$1.65	USD	2 Qtrs
Net (loss) income	`EarningsPerShareBasic`	$0.96	USD	1 Quarter
Net (loss) income	`EarningsPerShareBasic`	$-12.91	USD	1 Quarter
Net (loss) income	`EarningsPerShareBasic`	$-12.85	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.01	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-12.82	USD	2 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-12.90	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.80	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.03	USD	2 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.06	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.17	USD	2 Qtrs
Net (loss) income	`EarningsPerShareDiluted`	$1.64	USD	2 Qtrs
Net (loss) income	`EarningsPerShareDiluted`	$-12.91	USD	1 Quarter
Net (loss) income	`EarningsPerShareDiluted`	$0.95	USD	1 Quarter
Net (loss) income	`EarningsPerShareDiluted`	$-12.85	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	114.81M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	110.56M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	115.19M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	110.88M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	110.56M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	110.88M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	116.10M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.58M	shares	2 Qtrs

Cash Flow Statement 91 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$232.00M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-1.41B	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$134.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.37B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$588.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$574.00M	USD	2 Qtrs
Government settlement and related costs	`LossContingencyAccrualProvision`	$1.00M	USD	2 Qtrs
Government settlement and related costs	`LossContingencyAccrualProvision`	$1.00M	USD	2 Qtrs
Government settlement and related costs	`LossContingencyAccrualProvision`	$-6.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$30.00M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$12.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$15.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$26.00M	USD	2 Qtrs
Loss on sale, net	`GainLossOnDispositionOfAssets1`	$-1.00M	USD	2 Qtrs
Impairment of hospitals sold or held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOfOrSold`	$2.00M	USD	2 Qtrs
Impairment of hospitals sold or held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOfOrSold`	$1.00M	USD	2 Qtrs
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$6.00M	USD	1 Quarter
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$1.66B	USD	2 Qtrs
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$6.00M	USD	2 Qtrs
Impairment of goodwill and long-lived assets	`AssetImpairmentCharges`	$1.64B	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.00M	USD	2 Qtrs
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-16.00M	USD	2 Qtrs
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-30.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-9.00M	USD	1 Quarter
Gain on sale of investments in unconsolidated affiliates	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$94.00M	USD	2 Qtrs
Gain on sale of investments in unconsolidated affiliates	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$94.00M	USD	1 Quarter
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$1.00M	USD	2 Qtrs
Other non-cash expenses, net	`OtherNoncashIncomeExpense`	$-22.00M	USD	2 Qtrs
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$40.00M	USD	2 Qtrs
Patient accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$88.00M	USD	2 Qtrs
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$30.00M	USD	2 Qtrs
Supplies, prepaid expenses and other current assets	`IncreaseDecreaseInSuppliesPrepaidExpensesAndOtherCurrentAssets`	$-31.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-238.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and income taxes	`IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndIncomeTaxes`	$-212.00M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$15.00M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-8.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$504.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$632.00M	USD	2 Qtrs
Acquisitions of facilities and other related equipment	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$114.00M	USD	2 Qtrs
Acquisitions of facilities and other related equipment	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$27.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$407.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$474.00M	USD	2 Qtrs
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$12.00M	USD	2 Qtrs
Proceeds from disposition of hospitals and other ancillary operations	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$62.00M	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$11.00M	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00M	USD	2 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecurities`	$90.00M	USD	2 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecurities`	$63.00M	USD	2 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$233.00M	USD	2 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$86.00M	USD	2 Qtrs
Proceeds from the sale of investments in unconsolidated affiliates	`ProceedsFromSaleOfEquityMethodInvestments`	$403.00M	USD	2 Qtrs
Distribution from Quorum Health Corporation	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$1.22B	USD	2 Qtrs
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$80.00M	USD	2 Qtrs
Increase in other investments	`PaymentsForProceedsFromOtherInvestingActivities`	$113.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-512.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.18B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$22.00M	USD	2 Qtrs
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.00M	USD	2 Qtrs
Repurchase of restricted stock shares for payroll tax withholding requirements	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$20.00M	USD	2 Qtrs
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$22.00M	USD	2 Qtrs
Deferred financing costs and other debt-related costs	`PaymentsOfFinancingCosts`	$30.00M	USD	2 Qtrs
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$16.00M	USD	2 Qtrs
Redemption of noncontrolling investments in joint ventures	`PaymentsToMinorityShareholders`	$14.00M	USD	2 Qtrs
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$47.00M	USD	2 Qtrs
Distributions to noncontrolling investors in joint ventures	`PaymentsOfDividendsMinorityInterest`	$48.00M	USD	2 Qtrs
Borrowings under credit agreements	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$2.81B	USD	2 Qtrs
Borrowings under credit agreements	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$2.38B	USD	2 Qtrs
Proceeds from receivables facility	`ProceedsFromAccountsReceivableSecuritization`	$91.00M	USD	2 Qtrs
Proceeds from receivables facility	`ProceedsFromAccountsReceivableSecuritization`	$31.00M	USD	2 Qtrs
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$2.52B	USD	2 Qtrs
Repayments of long-term indebtedness	`RepaymentsOfLongTermDebt`	$4.28B	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.53B	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-136.00M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-144.00M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$277.00M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$184.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$365.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$509.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$461.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$184.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$365.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$509.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$461.00M	USD	Point-in-time
Interest payments	`InterestPaidNet`	$159.00M	USD	1 Quarter
Interest payments	`InterestPaidNet`	$459.00M	USD	2 Qtrs
Interest payments	`InterestPaidNet`	$489.00M	USD	2 Qtrs
Interest payments	`InterestPaidNet`	$182.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$8.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$4.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$4.00M	USD	2 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$9.00M	USD	2 Qtrs

Comprehensive Income 31 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$232.00M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-1.41B	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$134.00M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.37B	USD	2 Qtrs
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-2.00M	USD	1 Quarter
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	2 Qtrs
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$8.00M	USD	1 Quarter
Net change in fair value of interest rate swaps, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-21.00M	USD	2 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-3.00M	USD	1 Quarter
Net change in fair value of available-for-sale securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Amortization and recognition of unrecognized pension cost components, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Amortization and recognition of unrecognized pension cost components, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-3.00M	USD	2 Qtrs
Amortization and recognition of unrecognized pension cost components, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-3.00M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$6.00M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-19.00M	USD	2 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-1.00M	USD	2 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.41B	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$231.00M	USD	2 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$140.00M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.39B	USD	2 Qtrs
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$26.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$23.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$50.00M	USD	2 Qtrs
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$43.00M	USD	2 Qtrs
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-1.44B	USD	1 Quarter
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$117.00M	USD	1 Quarter
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$-1.44B	USD	2 Qtrs
Comprehensive (loss) income attributable to Community Health Systems, Inc. stockholders	`ComprehensiveIncomeNetOfTax`	$188.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.